EdgarLookup
SC 13G

CORBUS PHARMACEUTICALS HOLDINGS, INC.

Company
Corbus Pharmaceuticals Holdings, Inc.
Filed
January 29, 2024
Accession Number
0000902664-24-000754

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →